RSVAX | VEVYX | RSVAX / VEVYX | |
Total Expense Ratio | 1.30 | 0.66 | 197% |
Annual Report Gross Expense Ratio | 1.33 | 0.66 | 202% |
Fund Existence | 32 years | 13 years | - |
Gain YTD | 1.043 | 0.751 | 139% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 249M | 16.6B | 2% |
Annual Yield % from dividends | 0.37 | 1.02 | 36% |
Returns for 1 year | -10.45 | -12.29 | 85% |
Returns for 3 years | 7.13 | 7.07 | 101% |
Returns for 5 years | 21.74 | 31.88 | 68% |
Returns for 10 years | -19.07 | 48.25 | -40% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LRGG | 29.26 | 0.22 | +0.76% |
Macquarie Focused Large Growth ETF | |||
FLJP | 35.18 | 0.16 | +0.46% |
Franklin FTSE Japan ETF | |||
MAPP | 26.44 | 0.04 | +0.15% |
Harbor Multi-Asset Explorer ETF | |||
XJR | 41.98 | 0.04 | +0.08% |
iShares ESG Select Scrn S&P Small-CapETF | |||
SPSK | 18.57 | -0.02 | -0.11% |
SP Funds Dow Jones Global Sukuk ETF |